Questions Swirl Around US Aflibercept With Biocon Decision Imminent
West Virginia Court Decision Comes Ahead Of Key May 2024 Reg. Exclusivity End
Executive Summary
Biocon’s ongoing legal battle with Regeneron over US patents shielding Eylea was discussed by the originator at a pair of recent healthcare conferences, with a decision due any day.